Ploidy shapes gemcitabine response through altered potency and delayed cell death
Vural Tagal, Jackson P. Cole, Tao Li, Rikhil J Kumar, Jordan Albrecht, Pujan Shrestha, Didem Ilter, Daria Miroshnychenko, Stanislav Drápela, Kayode D. Olumoyin, John Kyei, Mark Davies, Andriy Marusyk, Stuart R. Maudsley, Xiaoqing Yu, , Noemi Andor
This study shows that higher ploidy reduces gemcitabine potency and delays cell death by altering drug exposure kinetics and response timing.
bioRxiv · Sep 12, 2026 · PreprintCancer Biology